• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿石症风险测试:在使用结晶抑制剂(柠檬酸盐和植酸盐)评估肾结石治疗中的作用。

Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).

作者信息

Conte A, Pizá P, García-Raja A

机构信息

Servicio de Urologío, Servicio de Análisis Clínicos, Hospital Universitario Son Dureta, Palma de Mallorca, Spain.

出版信息

Arch Esp Urol. 1999 Jan-Feb;52(1):94-9.

PMID:10101897
Abstract

OBJECTIVES

This paper presents the results of a test to globally determine the urinary risk factor of calcium stone formation in the evaluation of treatments using crystallization inhibitors, such as citrate and phytate.

METHODS

Three groups of active calcium oxalate stone-formers have been selected. The lithogen urinary risk was determined using a specially designed disposable test before any medical treatment. After evaluation group I did not receive any treatment, group II was treated with potassium citrate and group III with a phytate-rich dietary complement. When 15 days had elapsed, the test to evaluate the risk of urinary calcium stone formation was applied again to the three groups. The main lithogenic biochemical parameters of each tested urine were also determined before and after treatment.

RESULTS

An important number of calcium oxalate stone-formers with high urinary risk factor (positive test) became negative after medical treatment (52% of the citrate-treated patients and 50% of the phytate-treated patients), but only 7% of the untreated patients (1 patient) showed a decrease in their urinary risk factor for calcium stones (negative test) after 15 days had elapsed. When the treatment was not effective, in an important number of cases, the urine contained high levels of calcium or showed pH values greater than 6.5.

CONCLUSION

From the obtained results it can be concluded that the test is useful to evaluate the efficacy of a given renal lithiasis medical treatment, and also the efficacy of the treatment of calcium oxalate renal lithiasis using crystallization inhibitors, such as citrate and phytate, in an important number of cases.

摘要

目的

本文介绍了一项测试的结果,该测试旨在全面确定在使用结晶抑制剂(如柠檬酸盐和植酸盐)进行治疗评估时钙结石形成的尿液风险因素。

方法

选择了三组活性草酸钙结石形成者。在任何医学治疗之前,使用专门设计的一次性测试来确定结石形成的尿液风险。评估后,第一组未接受任何治疗,第二组用柠檬酸钾治疗,第三组用富含植酸盐的饮食补充剂治疗。15天后,再次对三组进行评估尿钙结石形成风险的测试。还在治疗前后测定了每次测试尿液的主要结石形成生化参数。

结果

大量具有高尿液风险因素(测试阳性)的草酸钙结石形成者在医学治疗后变为阴性(52%的柠檬酸盐治疗患者和50%的植酸盐治疗患者),但只有7%的未治疗患者(1名患者)在15天后显示其钙结石尿液风险因素降低(测试阴性)。当治疗无效时,在许多情况下,尿液中钙含量高或pH值大于6.5。

结论

从获得的结果可以得出结论,该测试可用于评估给定肾石病医学治疗的疗效,以及在许多情况下使用结晶抑制剂(如柠檬酸盐和植酸盐)治疗草酸钙肾石病的疗效。

相似文献

1
Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).尿石症风险测试:在使用结晶抑制剂(柠檬酸盐和植酸盐)评估肾结石治疗中的作用。
Arch Esp Urol. 1999 Jan-Feb;52(1):94-9.
2
Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).尿石形成风险测试:在使用结晶抑制剂(柠檬酸盐和植酸盐)评估肾结石治疗中的作用。
Arch Esp Urol. 1999 Apr;52(3):305-10.
3
Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.枸橼酸钾疗法对钙结石形成的生理及物理化学纠正与预防作用
Trans Assoc Am Physicians. 1983;96:294-305.
4
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.饮食中补充钠治疗的低枸橼酸钙草酸钙结石患者尿结石危险因素的变化
J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.
5
Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.草酸钙结石抑制剂:其相互作用对草酸钙结晶的影响。
Urology. 2012 Nov;80(5):1163.e13-8. doi: 10.1016/j.urology.2012.04.040. Epub 2012 Jun 27.
6
Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.影响二水合草酸钙碎结石再生长的因素。
BMC Urol. 2006 Jul 5;6:16. doi: 10.1186/1471-2490-6-16.
7
Alkaline citrate in prevention of recurrent calcium oxalate stones.碱性柠檬酸盐预防草酸钙结石复发
Scand J Urol Nephrol Suppl. 1990;130:1-83.
8
Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.体外影响肾结石再生长的因素:对理解肾结石形成的贡献
Scand J Urol Nephrol. 2005;39(3):194-9. doi: 10.1080/00365590510031101.
9
Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.卧床休息5周期间,柠檬酸钾镁可降低肾结石风险。
J Urol. 2007 Jun;177(6):2179-84. doi: 10.1016/j.juro.2007.01.156.
10
Effects of citrate on the different phases of calcium oxalate crystallization.柠檬酸盐对草酸钙结晶不同阶段的影响。
Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90.